The Antibody Society

the official website of the antibody society

The Adaptive Immune Receptor Repertoire Community of The Antibody Society

  • LOG IN
  • BECOME A MEMBER
  • About
    • Mission & Activities
    • Directors and Officers
    • The Antibody Society’s Committees
      • Communication & Membership Committee
      • Meetings Committee
      • AIRR Community Working Groups & Subcommittees
    • Sponsors & Partners
  • Society meetings
    • Computational Antibody Discovery: State of the Art
      • Computational Antibody Discovery Symposium Participants
    • Harnessing Cytokines for Cancer Immunotherapy Symposium
    • Biopharmaceutical Informatics Symposium
    • Emerging Cancer Therapies Leveraging Gamma-Delta Effector T cells Symposium
    • Emerging Immunotherapeutics for Ovarian Cancer Symposium
    • AIRR Community Meetings
    • Antibody Engineering & Therapeutics (US) 2023
      • 2022 Antibody Engineering & Therapeutics
      • 2020 Antibody Engineering & Therapeutics
      • 2019 Antibody Engineering & Therapeutics
      • 2018 Antibody Engineering & Therapeutics
      • What is INN a Name?
        • INN issue updates
    • Antibody Engineering & Therapeutics Europe 2023
      • Scientific Advisors, Antibody Engineering & Therapeutics Europe
    • FOCIS Symposia
  • AIRR Community
    • AIRR News
    • AIRR Community Seminar Series
    • AIRR Publications
    • AIRR Meetings
      • AIRR Community Meeting VII – Learnings and Perspectives
      • AIRR Community Special Event 2023  – Zooming in to the Community II
      • AIRR Community Meeting VI: “Exploring New Frontiers”
      • AIRR Community Meeting V: “Zooming in to the AIRR Community”
      • AIRR Community Meeting V Pre-Meetings
        • AIRR-seq in the Pandemic
        • AIRR-seq Biological Standards and Workflows
      • AIRR Community Special Event: “Response to COVID-19”
      • AIRR Community Meeting IV: “Bridging the Gaps”
      • AIRR Community Meeting III
        • Day 1
        • Day 2
        • Day 3
        • Day 4
      • AIRR Community Meeting II
      • AIRR Community Meeting I
    • AIRR Community Working Groups
      • Biological Resources Working Group
      • Common Repository Working Group
      • Diagnostics Working Group
      • Germline Database Working Group
      • Legal and Ethics Working Group
      • Software Working Group
      • Standards Working Group
    • AIRR Community Sub-committees
      • Communications Sub-committee
      • Executive Sub-committee
      • Inferred Allele Review Committee
      • Meetings Sub-committee
      • Strategic Planning Sub-Committee
    • AIRR Data Commons
    • AIRR Community Calendar
    • AIRR Community Webinar Series
    • On AIRR – An AIRR Community Podcast
    • AIRR Community Resources
    • AIRR Community Service Prize 2022
  • Members only
    • Login
    • Note to members
    • Member discount codes
    • 2023 Calendar of Events
    • 2024 Calendar of Events
    • James S. Huston Antibody Science Talent Award
      • 2022 James S. Huston Antibody Science Talent Award Recipient
      • 2021 James S. Huston Antibody Science Talent Award Recipient
      • 2020 James S. Huston Antibody Science Talent Award Recipient
      • Huston Award Criteria
    • Research Competitions
      • Research Competition Winners
    • Science Writing Competition
      • Science Writing Competition Winners
    • Imaging Competition
      • Imaging Calendar Competition winners
        • The Antibody Society 2024 Calendar
    • Antibodies in early-stage studies
    • Presentations
  • Upcoming meetings
  • Web Resources
    • Society Publications
    • Antibody News
    • Antibody therapeutics approved or in regulatory review in the EU or US
      • Antibody therapeutics product data
    • Antibodies in late-stage clinical studies
    • Research Resources
    • Education Resources
  • Career Center
    • Career Shorts
  • Learning Center
    • Upcoming Webinars
    • Snakebite antivenoms: Global challenges and progress toward recombinant antibody therapeutics
    • Adaptive Immune Receptor Repertoires
    • Antibody Discovery & Development
    • Commercializing Antibody Therapeutics
    • Antibodies to Watch
    • Antibody Validation
      • 4th International Antibody Validation Meeting, Sep 2023
You are here: Home / The AIRR Community

The AIRR Community

The Adaptive Immune Receptor Repertoire (AIRR) Community of The Antibody Society is a research-driven group that is organizing and coordinating stakeholders in the use of next-generation sequencing technologies to study antibody/B-cell and T-cell receptor repertoires. Recent advances in sequencing technology have made it possible to sample the immune repertoire in exquisite detail. AIRR sequencing (AIRR-seq) has enormous promise for understanding the dynamics of the immune repertoire in vaccinology, infectious diseases, autoimmunity, and cancer biology, but also poses substantial challenges. The AIRR Community was established to meet these challenges.

If you are interested in learning more about the AIRR Community, please contact “info@airr-community.org” or visit the membership page and support AIRR research by becoming a member (students & postdocs are free) of this dynamic community.

The AIRR Community and its associated meetings and workshops are designed to develop and promote standards and recommendations for:

  • obtaining, analyzing, curating and comparing/sharing AIRR-seq datasets;
  • reviewing AIRR-seq data analysis tools for AIRR compliance;
  • relating AIRR-seq datasets to other “big data” sets, such as microarray, flow cytometric, and MiSeq and single-cell gene-expression data; and
  • legal and ethical issues involving the use and sharing of AIRR-seq data sets derived from human sources.

The proceedings of the workshops, including the recommendations and action plans, are published to benefit the larger scientific community. The AIRR-C Comms is active on social media. To stay connected and learn the latest news in the AIRR Community, follow us on X, LinkedIn, Mastodon, or BlueSky, subscribe to our YouTube Channel, or check out the AIRR News page. You can also explore the B-T.CR forum and wiki and join the AIRR-C Slack.

What is the AIRR Community?

The idea of forming an Open Science grassroots community working with AIRR-seq data was the brainchild of Jamie Scott, Tom Kepler, and Felix Breden. From its conception in 2014, the AIRR Community grew and flourished, then joined The Antibody Society in 2018 as an official Committee. The AIRR Community now comprises a multidisciplinary group of several hundred stakeholders who are dedicated to the development of methods and standards for the generation, analysis and sharing of AIRR-seq data. Seven Working Groups and four Sub-Committees publish research articles describing standards for the generation, annotation, storage and sharing of AIRR-seq data following FAIR principles.

One result of these standards is the establishment of the AIRR Data Commons which provides public access to more than 80 MiARR compliant studies, including many COVID-19 studies, and their AIRR-seq data for query and download.  The Community also organizes meetings and workshops to report progress in the field and promote its standards as well as webinars and seminars to promote AIRR-seq related research. The governance structure of the AIRR Community (adopted 2020.03.26) can be found in the Community Resources “members only” section.

AIRR Community Meetings

The AIRR Community is excited to be planning their seventh Meeting AIRR Community Meeting VII – Learnings and Perspectives which will be held in Porto, Portugal on June 3-6, 2024. Save the Date!

For complete details about all AIRR Community Meetings, visit the AIRR-C Meetings page.

Benefits of Membership

Active members of the AIRR Community are involved in one or more of its Working Groups and Sub-Committees. These international groups meet regularly and are working on topics ranging from the validation and designation of germline V genes, software and data standards, addressing legal and ethical issues arising from the production, use and sharing of AIRR-seq data, to meeting planning. Natural networks of collaboration arise organically from these highly interactive projects. Thus, as a member of the AIRR Community, you will join a network of experts in the field who are actively solving real-world problems for the good of the scientific community.

AIRR Community News

Join us for the next AIRR-C webinar on Dec 7th!

December 1, 2023 By Edel Aron

Explore with us the state-of-the-art in TCR-Epitope prediction. T-cells are at the heart of the immune system’s ability to distinguish between self and non-self, playing a critical role in both health and disease. Given the sheer scale of potential TCR-epitope interactions (stemming from both the enormous epitope and TCR repertoire diversity) experimental validation of each […]

The AIRR-C seminars are back on Nov 30th!

November 29, 2023 By Edel Aron

The November AIRR-C seminar is fast approaching! On November 30th at 7:00 PST/10:00 EST/16:00 CET,  Aaron Michels of the University of Colorado Anschutz Medical Campus will be presenting “Temporal Development of T cell receptor Repertoires during Childhood in Health and Type 1 Diabetes” and Julien Limenitakis of the University of Bern will be presenting “Diet […]

AIRR-C WG/SC Calls

All times are in ET (Americas/New York)

Click here for full calendar view

Common Repository WG
11:00
Thu, December 7, 2023
Meetings SC
12:00
Fri, December 8, 2023
Standards WG
14:00
Mon, December 11, 2023
Executive SC
11:00
Thu, December 21, 2023
Meetings SC
12:00
Fri, December 22, 2023

Recent AIRR Publications

Lees W.D. et al. AIRR Community curation and standardised representation for immunoglobulin and T cell receptor germline sets (Immunoinformatics, 2023)

See all publications

Archives

AIRR-C Glossary of Terms

Follow Us Online

  • Email
  • LinkedIn
  • Twitter
  • YouTube
  • Slack
  • Home
  • Privacy & Terms of Use
  • About
  • Directors and Officers
  • Advisors
  • Sponsors & Partners
  • Mission & Activities
  • Join the Society
  • Membership Levels
  • Members only
  • Login
  • Antibody therapeutics approved or in regulatory review in the EU or US
  • Meeting reports
  • Presentations
  • Contact

©2015 - scicomvisuals